viewLexaGene Holdings Inc.

Full interview: Lexagene makes key hire as they hope to have their LX Analyzer to market in Q-3

Lexagene (CVE: LXG- OTCQB: LXXGF) Co-Founder and CEO Dr Jack Regan joined Steve Darling from Proactive Vancouver to discuss the hiring of Steven Armstrong as the company’s Senior Director of Operations. Regan explains the skills he is bringing to the job.

Regan also told Proactive the latest on manufacturing its flagship LX Genetic Analyzer for rapid pathogen detection. Lexagene recently revealed that it is accelerating the submission of its LX Analyzer to the FDA as the COVID-19 outbreak expands.

Quick facts: LexaGene Holdings Inc.

Price: 0.82 CAD

Market: TSX-V
Market Cap: $93.24 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of LexaGene Holdings Inc. named herein, including the promotion by the Company of LexaGene Holdings Inc. in any Content on the Site, the Company...


LexaGene announces first contract for MiQLab system by major biotech company

LexaGene (CVE: LXG-OTCQB: LXXGF) CEO Dr. Jack Regan joined Steve Darling from Proactive to bring news the company has received a purchase order for the MiQLab system from a multinational biotechnology company that generates billions in annual revenue. Regan says this company was looking...

2 weeks, 1 day ago

2 min read